Ligand validation:7SBN

GLN: GLUTAMINE

GLN is a Ligand Of Interest in 7SBN designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7SBN_GLN_B_601	78%	53%	0.111	0.955	0.71	1.08	-	1	1	0	100%	1
7SBN_GLN_D_601	70%	55%	0.131	0.948	0.77	0.97	-	1	0	0	100%	1
7SBN_GLN_A_601	68%	50%	0.141	0.954	0.71	1.22	-	2	0	0	100%	1
7SBN_GLN_C_601	25%	58%	0.23	0.863	0.7	0.89	-	1	0	0	100%	1
7SBM_GLN_C_601	47%	47%	0.198	0.938	0.86	1.21	1	2	5	0	100%	1
8B5D_GLN_B_404	95%	51%	0.065	0.969	1.12	0.8	1	-	3	0	100%	1
4ZV2_GLN_A_301	93%	44%	0.083	0.977	0.85	1.36	1	2	0	0	100%	1
2NV2_GLN_P_6032	91%	46%	0.075	0.963	1	1.11	1	2	2	0	100%	1
4N0I_GLN_A_501	80%	46%	0.091	0.958	0.94	1.16	1	-	1	0	90%	0.9
5DDP_GLN_B_101	76%	56%	0.138	0.976	0.75	0.93	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.